Get started
Larimar Therapeutics, Inc.Larimar Therapeutics, Inc.Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

LRMR chart


Full chart

LRMR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪252.67 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.15 USD
Net income (FY)
‪−36.95 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪37.01 M‬
Beta (1Y)
1.85

Employees


Employees (FY)
42
Change (1Y)
+16 +61.54%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−879.74 K‬ USD

About Larimar Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Carole S. Ben-Maimon
Website
larimartx.com
Headquarters
Bala Cynwyd
Founded
2005
FIGI
BBG001J2NVH0
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

LRMR news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of LRMR is 3.78 USD — it has decreased by −1.25% in the past 24 hours. Watch Larimar Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Larimar Therapeutics, Inc. stocks are traded under the ticker LRMR.
LRMR stock has risen by 0.25% compared to the previous week, the month change is a −35.71% fall, over the last year Larimar Therapeutics, Inc. has showed a −6.67% decrease.
We've gathered analysts' opinions on Larimar Therapeutics, Inc. future price: according to them, LRMR price has a max estimate of 36.00 USD and a min estimate of 12.36 USD. Watch LRMR chart and read a more detailed Larimar Therapeutics, Inc. stock forecast: see what analysts think of Larimar Therapeutics, Inc. and suggest that you do with its stocks.
LRMR reached its all-time high on Mar 20, 2015 with the price of 664.32 USD, and its all-time low was 1.53 USD and was reached on Aug 5, 2022. View more price dynamics on LRMR chart.
See other stocks reaching their highest and lowest prices.
LRMR stock is 6.97% volatile and has beta coefficient of 1.85. Track Larimar Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Larimar Therapeutics, Inc. there?
Today Larimar Therapeutics, Inc. has the market capitalization of ‪252.67 M‬, it has decreased by −33.54% over the last week.
Yes, you can track Larimar Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Larimar Therapeutics, Inc. is going to release the next earnings report on Mar 12, 2025. Keep track of upcoming events with our Earnings Calendar.
LRMR earnings for the last quarter are −0.24 USD per share, whereas the estimation was −0.37 USD resulting in a 35.95% surprise. The estimated earnings for the next quarter are −0.32 USD per share. See more details about Larimar Therapeutics, Inc. earnings.
Larimar Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
LRMR net income for the last quarter is ‪−15.50 M‬ USD, while the quarter before that showed ‪−21.63 M‬ USD of net income which accounts for 28.33% change. Track more Larimar Therapeutics, Inc. financial stats to get the full picture.
No, LRMR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 42.00 employees. See our rating of the largest employees — is Larimar Therapeutics, Inc. on this list?
Like other stocks, LRMR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Larimar Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Larimar Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Larimar Therapeutics, Inc. stock shows the strong sell signal. See more of Larimar Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.